Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,330 INR | +2.01% | +3.10% | -1.96% |
24/05 | Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution | MT |
16/05 | Caplin Point Laboratories to Seek Acquisitions | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.96% | 118.57Cr | |
+17.44% | 4.23TCr | |
+19.46% | 2.25TCr | |
+16.96% | 1.52TCr | |
+19.53% | 1.43TCr | |
+52.20% | 1.26TCr | |
-0.05% | 678.76Cr | |
-11.11% | 670.62Cr | |
-8.87% | 572.55Cr | |
+14.27% | 546.57Cr |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Transcript : Caplin Point Laboratories Limited, Q4 2022 Earnings Call, May 12, 2022